Diabetes, Obesity and Metabolism

Cover image for Vol. 18 Issue 7

Accepted Articles (Accepted, unedited articles published online and citable. The final edited and typeset version of record will appear in future.)

Edited By: R. Donnelly and A. Garber

Impact Factor: 6.198

ISI Journal Citation Reports © Ranking: 2015: 13/131 (Endocrinology & Metabolism)

Online ISSN: 1463-1326


  1. 1 - 18

    1. Dogfish glucagon analogues counter hyperglycaemia and enhance both insulin secretion and action in diet-induced obese diabetic mice

      F.P.M. O'Harte, M.T. Ng, A.M. Lynch, J.M. Conlon and P.R. Flatt

      Accepted manuscript online: 30 JUN 2016 02:08AM EST | DOI: 10.1111/dom.12713

    2. Basal insulin peglispro vs insulin glargine in insulin-naïve type 2 diabetes: IMAGINE 2 randomized trial

      M. J. Davies, D. Russell-Jones, J.-L. Selam, T. S. Bailey, Z. Kerényi, J. Luo, J. Bue-Valleskey, T. Iványi, M. L. Hartman, J. G. Jacobson, S. J. Jacober and for the IMAGINE 2 Study Investigators

      Accepted manuscript online: 28 JUN 2016 03:26AM EST | DOI: 10.1111/dom.12712


    1. GIP secretion is induced by inflammatory stimuli in an IL-1-dependent manner in mice

      Florian Kahles, Christina Meyer, Sebastian Diebold, Ann Christina Foldenauer, Robert Stöhr, Julia Möllmann, Corinna Lebherz, Hannes M Findeisen, Nikolaus Marx and Michael Lehrke

      Accepted manuscript online: 28 JUN 2016 03:21AM EST | DOI: 10.1111/dom.12711


    1. Individualized prediction of the effect of angiotensin receptor inhibition on renal and cardiovascular outcomes in patients with diabetic nephropathy

      Nicolette G.C. van der Sande, Jannick A.N. Dorresteijn, Frank. L.J. Visseren, Jamie P. Dwyer, Peter J. Blankestijn, Yolanda van der Graaf and Hiddo L. Heerspink

      Accepted manuscript online: 23 JUN 2016 07:30AM EST | DOI: 10.1111/dom.12708


    1. Dose–response relationship between statin therapy and glycaemia in community-based patients with type 2 diabetes: The Fremantle Diabetes Study

      Timothy M E Davis, Imran Badshah, S A Paul Chubb and Wendy A Davis

      Accepted manuscript online: 23 JUN 2016 07:25AM EST | DOI: 10.1111/dom.12710


    1. Effects of vitamin D supplementation on HbA1c and fasting glucose in hypertensive patients - a randomized controlled trial

      Martin R. Grübler, Martin Gaksch, Katharina Kienreich, Nicolas Verheyen, Johannes Schmid, Bríain ó Hartaigh, Georg Richtig, Hubert Scharnagl, Andreas Meinitzer, Astrid Fahrleitner-Pammer, Winfried März, Andreas Tomaschitz and Stefan Pilz

      Accepted manuscript online: 23 JUN 2016 07:25AM EST | DOI: 10.1111/dom.12709

    2. Randomized trial of a dual-hormone artificial pancreas with dosing adjustment during exercise compared with no adjustment and sensor-augmented pump therapy

      Peter G. Jacobs, Joseph El Youssef, Ravi Reddy, Navid Resalat, Deborah Branigan, John Condon, Nick Preiser, Katrina Ramsey, Madeleine Jones, Christopher Edwards, Kerry Kuehl, Joseph Leitschuh, Uma Rajhbeharrysingh and Jessica Castle

      Accepted manuscript online: 23 JUN 2016 07:25AM EST | DOI: 10.1111/dom.12707

    3. Cardiovascular Safety of Glucose-Lowering Agents as Add-on Medication to Metformin Treatment in Type 2 Diabetes:Report from the Swedish National Diabetes Register (NDR)

      Nils Ekström, Ann-Marie Svensson, Mervete Miftaraj, Stefan Franzén, Björn Zethelius, Björn Eliasson and Soffia Gudbjörnsdottir

      Accepted manuscript online: 10 JUN 2016 04:15AM EST | DOI: 10.1111/dom.12704

    4. Continuous Glucose Monitoring in Type 2 Diabetes Patients Treated with GLP-1 Receptor Agonist Dulaglutide in Combination with Prandial Insulin Lispro – An AWARD-4 Substudy

      Johan Jendle, Marcia A. Testa, Sherry Martin, Honghua Jiang and Zvonko Milicevic

      Accepted manuscript online: 9 JUN 2016 08:42AM EST | DOI: 10.1111/dom.12705


    1. The Euglycaemic Glucose Clamp: What it can and cannot do – and how to do it

      T. Heise, E. Zijlstra, L. Nosek, S. Heckermann, L. Plum-Mörschel and T. Forst

      Accepted manuscript online: 9 JUN 2016 08:41AM EST | DOI: 10.1111/dom.12703


    1. Effect of testosterone on insulin sensitivity, oxidative metabolism, and body-composition in aging men with type 2 diabetes on metformin monotherapy

      L.V. Magnussen, D. Glintborg, P. Hermann, D.M. Hougaard, K. Højlund and M. Andersen

      Accepted manuscript online: 6 JUN 2016 06:09AM EST | DOI: 10.1111/dom.12701


    1. Baseline Factors Associated with Glycaemic Response to Treatment with Once Weekly Dulaglutide in Patients with Type 2 Diabetes

      Carol Wysham, Bruno Guerci, David D'Alessio, Nan Jia and Fady T. Botros

      Accepted manuscript online: 6 JUN 2016 06:08AM EST | DOI: 10.1111/dom.12702

    2. Efficacy and safety of empagliflozin in patients with type 2 diabetes from Asian countries: pooled data from four Phase III trials

      K-H. Yoon, R. Nishimura, J. Lee, S. Crowe, A. Salsali, T. Hach and H.J. Woerle

      Accepted manuscript online: 6 JUN 2016 06:08AM EST | DOI: 10.1111/dom.12699


    1. Involvement of Glucagon-like Peptide-1 in the Glucose-lowering effect of Metformin

      Emilie Bahne, Morten Hansen, Andreas Brønden, David P. Sonne, Tina Vilsbøll1 and Filip K. Knop

      Accepted manuscript online: 6 JUN 2016 06:08AM EST | DOI: 10.1111/dom.12697


    1. You have full text access to this OnlineOpen article
      A Randomized, Double-Blind Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine, in Combination with Prandial Insulin Lispro, in Patients with Type 1 Diabetes: IMAGINE 3

      Richard M. Bergenstal, Helen Lunt, Edward Franek, Florence Travert, Jiani Mou, Yongming Qu, Caryl J. Antalis, Mark L. Hartman, Myriam Rosilio, Scott J. Jacober, Edward J Bastyr III and on behalf of the IMAGINE 3 Trial Investigators

      Accepted manuscript online: 6 JUN 2016 06:07AM EST | DOI: 10.1111/dom.12698

    2. Addition of sulphonylurea to metformin does not relevantly change bodyweight: A prospective observational cohort study (ZODIAC-39)

      Dennis Schrijnders, Raiza Wever, Nanne Kleefstra, Sebastiaan T Houweling, Kornelis JJ van Hateren, Geertruida H de Bock, Henk JG Bilo, Klaas H Groenier and Gijs WD Landman

      Accepted manuscript online: 6 JUN 2016 06:05AM EST | DOI: 10.1111/dom.12700


    1. Add-on treatment with intermediate-acting insulin versus sliding scale insulin for patients with type 2 diabetes or insulin resistance during cyclic glucocorticoid-containing antineoplastic chemotherapy – a randomized cross-over study

      Maaike C. Gerards, Josanne de Maar, Tessa G. Steenbruggen, Joost B. L. Hoekstra, Titia M. Vriesendorp and Victor E.A. Gerdes

      Accepted manuscript online: 18 MAY 2016 11:07AM EST | DOI: 10.1111/dom.12694


  1. 1 - 18